|
Volumn 129, Issue 1, 2011, Pages 106-107
|
Reduction in dose of intravitreous bevacizumab before vitrectomy for proliferative diabetic retinopathy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
VASCULOTROPIN;
AQUEOUS HUMOR;
ARTICLE;
CLINICAL ARTICLE;
DIABETIC RETINOPATHY;
DRUG DOSE COMPARISON;
DRUG DOSE REDUCTION;
DRUG EFFECT;
HUMAN;
PRIORITY JOURNAL;
RETINA DETACHMENT;
RETINA DISEASE;
TRACTION FOVEAL DETACHMENT;
VITRECTOMY;
VITREOUS HEMORRHAGE;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
AQUEOUS HUMOR;
DIABETIC RETINOPATHY;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
FLUORESCEIN ANGIOGRAPHY;
HUMANS;
INTRAVITREAL INJECTIONS;
MIDDLE AGED;
OFF-LABEL USE;
RETINAL NEOVASCULARIZATION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
VITRECTOMY;
|
EID: 78651339612
PISSN: 00039950
EISSN: 15383601
Source Type: Journal
DOI: 10.1001/archophthalmol.2010.333 Document Type: Article |
Times cited : (5)
|
References (5)
|